BRCA1/2 and Other Predisposition Genes in High-Risk Hormone Receptor+/Human Epidermal Growth Factor Receptor 2-Breast Cancer Treated with Endocrine Therapy with or Without Palbociclib: A Secondary PENELOPE-B Study Analysis - Hahnen E; Hauke J; Gelmon K; Marmé F; Ernst C; Martin M; Untch M; Bonnefoi H; Knudsen E; Im SA; Demichele A; VanT́ Veer L; et al. (Jco Precision Oncology, 2025)